Comparing the Two Top Stocks: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Carvana Co. (NYSE:CVNA)

earning reaction history, nasdaq, nyse

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) closed at $3.58 on the last trading session with an decrease of -0.83%, whereas, it previously closed at $3.61. The company has a market capitalization of $394.4 Million. The company traded shares of 1.18 Million on the trading day while its three month average volume stands at 2.33 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) produced diluted EPS of -1. The EPS estimate for next year as estimated by analysts is at -1.08 while EPS for next quarter is estimated at -0.31. Earnings per Share growth for this year is reported at -26, while the analysts estimated the EPS growth for next year at -1.08% and Earnings growth for next 5 years stands at 19.9% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -12.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands at 17.45 and Price to Book or P/B for the most recent quarter stands at 17.9. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) are reported at 1.8 and 1.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands at -71.7, -223.3 and -84.9 respectively

The trailing twelve month Revenue of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is reported at 22.6 Million with income of -106500000. The outstanding shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) are 110.17 Million. The institutional Ownership of the shares of 93.6 stands at 0.80%, this figure is increased 0.1 in the last six months. The insider ownership for the shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is ticked at 1%, the figure is plummeted -7.03% in the last six months.

Some other important financial aspects to be discussed here for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is the Mean Target Price estimated by the analysts which stands at 7.93. The 52 week high of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is placed at 9.95 and 52 week low is standing at 2.80.

Performance wise the shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) fell down -2.98% for the week, it also rise 0% for the monthly performance, while for the quarter it went up -58.8%. The shares decrease -57.38% for the half year and plummeted for the Year-To-Date performance. The shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shrinked -41.69% for the yearly performance.

Carvana Co. (NYSE:CVNA)

Carvana Co. (NYSE:CVNA) closed at $64.59 on the last trading session with an decrease of -4.52%, whereas, it previously closed at $67.65. The company has a market capitalization of $9.35 Billion. The company traded shares of 1.94 Million on the trading day while its three month average volume stands at 1.45 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Carvana Co. (NYSE:CVNA) produced diluted EPS of -2.33. The EPS estimate for next year as estimated by analysts is at -1.17 while EPS for next quarter is estimated at -0.42. Earnings per Share growth for this year is reported at 47, while the analysts estimated the EPS growth for next year at -1.17% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Carvana Co. (NYSE:CVNA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Carvana Co. (NYSE:CVNA) stands at 3.98 and Price to Book or P/B for the most recent quarter stands at 48.93. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Carvana Co. (NYSE:CVNA) are reported at 0.6 and 1.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Carvana Co. (NYSE:CVNA) stands at -7.8, -124 and -35.9 respectively

The trailing twelve month Revenue of Carvana Co. (NYSE:CVNA) is reported at 2.35 Billion with income of -86100000. The outstanding shares of Carvana Co. (NYSE:CVNA) are 144.69 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 2.08 in the last six months. The insider ownership for the shares of Carvana Co. (NYSE:CVNA) is ticked at 0.6%, the figure is plummeted -84.79% in the last six months.

Some other important financial aspects to be discussed here for Carvana Co. (NYSE:CVNA) is the Mean Target Price estimated by the analysts which stands at 70.36. The 52 week high of Carvana Co. (NYSE:CVNA) is placed at 76.85 and 52 week low is standing at 28.44.

Performance wise the shares of Carvana Co. (NYSE:CVNA) rose up 0.65% for the week, it also rise 5.4% for the monthly performance, while for the quarter it went down 2.61%. The shares increase 84.7% for the half year and flew up for the Year-To-Date performance. The shares of Carvana Co. (NYSE:CVNA) grew 46.33% for the yearly performance.